|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phos- phorylated Akt, and increases sensitivity to doxorubicin 显示文摘 | Tanaka M Grossman HB | 2003 | Gene Ther2003，10，19： | 1 |
| 2 | Medical management of renal actinomycosis 显示文摘 | Dhanani NN Jones DM Grossman HB | 2004 | J Urol2004，171，61： | 1 |
| 3 | The utility of fibrin/fibrinogen degradation products in superfcial bladder cancer显示文摘 | Tsihlias J Grossman HB | 2000 | Urol Clin North Am2000，27，： | 1 |
| 4 | Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival 显示文摘 | Leibovici D Grossman HB Dinney GP | 2005 | J Clin Oncol2005，23，24： | 1 |
| 5 | Refining patient selection for neoadjuvant chemotherapy before radical cysteetomy显示文摘 | CULP SH DICKSTEIN RJ GROSSMAN HB | 2014 | J Urol2014，191，1： | 1 |
| 6 | Connexin 26 is abnormally expressed in bladder cancer 显示文摘 | Gee J Tanaka M Grossman HB | 2003 | Urol2003，169，3： | 1 |
| 7 | A phase Ⅲ,multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopyfor the detection of superficial papillary lesions in pa-tients with bladder cancer显示文摘 | Grossman HB Gomella L Fradet Y | | 0，，01： | 1 |
| 8 | Selective Cox-2 inhibitors as chemopreventive and therapeutic agents显示文摘 | Grossman HB | 2003 | Drugs Today2003，39，3： | 1 |
| 9 | In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity todoxorubicin显示文摘 | Tanaka M Grossman HB | 2003 | Gene Therapy2003，10，： | 1 |
| 10 | Connexin 26 gene therapy of human bladder cancer: induction of growth suppression, apoptosis, and synergy with Cisplatin 显示文摘 | Tanaka M Grossman HB | 2001 | Hum Gene Ther2001，12，18： | 1 |
| 11 | Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer显示文摘 | Grossman HB Natale RB Tangen CM | 2003 | N Engl J Med2003，349，9： | 1 |
| 12 | Surgical factors influence bladder cancer outcomes:a cooperative group report显示文摘 | Herr HW Faulkner JR Grossman HB | 2004 | J Clin Oncol2004，22，14： | 1 |
| 13 | Surveillance for recurrent bladder cancer using a point-of-care proteomic assay显示文摘 | Grossman HB Soloway M Messing E | 2006 | JAMA2006，295，3： | 1 |
| 14 | Neoadjuvant chemo- therapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer 显示文摘 | Grossman HB Natale RB Tangen CM | 2003 | N Engl J Med2003，349，： | 1 |
| 15 | Bacillus calmette-gu&in failures and beyond: contemporary manage- ment of non-muscle-invasive bladder cancer显示文摘 | Grossman HB O'Donnell MA Cookson MS | 2008 | Rev Urol2008，10，4： | 1 |
| 16 | Bladder cancer predisposition:a multigenic approach to DNA-repair and cell-cycle-control genes显示文摘 | Wu X Gu J Grossman HB | 2006 | Am J Hum Genet2006，78，3： | 1 |
| 17 | A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle- invasive bladder cancer 显示文摘 | SABICHI AL LEE JJ GROSSMAN HB | 2011 | Cancer Preve Res2011，4，10： | 1 |
| 18 | Plasma levels of insulin-like growth factor- Ⅰ and binding protein-3, and their association with bladder cancer risk 显示文摘 | Zhao H Grossman HB Spitz MR | 2003 | J Urol2003，169，2： | 1 |
| 19 | Death receptor 4 and bladder cancer risk显示文摘 | Hazra A Chamberlain RM Grossman HB | 2003 | Cancer Res2003，63，6： | 1 |
| 20 | Connexin 26 is abnormally ex pressed in bladder cancer显示文摘 | Gee J Tanaka M Grossman HB | 2003 | J Urol2003，169，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员